# Enoxaparin Sodium

NDC: 63323-564
Generic name: Enoxaparin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20190423

FDA application: ANDA078990

## Active ingredients

- ENOXAPARIN SODIUM: 40 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-564"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-564
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3be543e-8aff-4311-bf77-e7a5a814ca6f